Price (delayed)
$15.92
Market cap
$858.23M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.15
Enterprise value
$826.28M
Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate,
There are no recent dividends present for CRNX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.